跳至主要内容
临床试验/EUCTR2012-004383-22-DE
EUCTR2012-004383-22-DE进行中(未招募)1 期

Perioperative complications in obese and non-obese patients: Prevention and treatment of wound infections and post-operative pain.Prospective, open, monocentric study to investigate perioperative tissue concentrations of antibiotics and regional analgesics using microdialysis in obese and non-obese patients. - Microdialysis

niversity of Leipzig0 个研究点开始时间: 2013年1月15日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -Obese (BMI = 35 kg/m2)
  • -age = 18 years
  • -patients undergoing an abdominal surgery and needing a perioperative prophylactic antibiotic and analgesics
  • -Written informed consent of the patient
  • Control group:
  • - BMI = 18,5 kg/m² und BMI < 30 kg/m²
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 90
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 90

排除标准

  • Exclusion Kriteria – Drug Group 1 (Linezolid, Meropenem and Paracetamol/Metamizol):
  • -Patients who have received the study medication within the 72 hours before surgery
  • -known allergic reactions, hypersensitivity or contra-indications to Propacetamol-HCl or Metamizol-Sodium, Carbapenem-Antibiotics, ß-Laktam-Antibiotics (e.g. Penicilline, Cephalosporine), Pyrazolone und Pyrazolidine
  • -sever liver insufficiency
  • -Patients with disorders of bone marrow functions (e.g. after treatment with cytostacics) or disorders of the hematopoiesis system
  • -genetic induced Glucose-6-phosphate dehydrogenase deficiency
  • -acute hepatic porphyria
  • -existing hypotony
  • -patients with phenylketonuria or hereditary fructose-intolerance
  • -within the previous tow weeks intake of drugs, which inhibit Monoaminooxidase A or B (e.g. Phenelzin, Isocarboxazid, Selegilin, Moclobemid)
  • -pregnant or breast-feeding women (positive pregnancy test for pre-menopausal women)
  • -participation in another interventional AMG study (studies falling in the jurisdiction of German Drug Law)
  • Exclusion Kriteria – Drug Group 2 (Tigecyclin and Paracetamol/ Metamizol):
  • -Patients who have received the study medication within the 72 hours before surgery
  • -known allergic reactions, hypersensitivity or contra-indications to Propacetamol-HCl or Metamizol-Sodium, Tigecycline, Tetracycline Antibiotics
  • -sever liver insufficiency
  • -Patients with disorders of bone marrow functions or disorders of the hematopoiesis system
  • -genetic induced Glucose-6-phosphate dehydrogenase deficiency (risk of hemolysis)
  • -acute hepatic porphyria
  • -existing hypotony
  • -pregnant or breast-feeding women (positive pregnancy test for pre-menopausal women)
  • -participation in another interventional AMG study (studies falling in the jurisdiction of German Drug Law)
  • Exclusion Kriteria – Drug Group 3 (Cefazolin, Metronidazol and Paracetamol/Metamizol):
  • -Patients who have received the study medication within the 72 hours before surgery
  • -known allergic reactions, hypersensitivity or contra-indications to Propacetamol-HCl or Metamizol-Sodium, Cephalosporins, other Cephalosporins, 5-Nitroimidazoles
  • -sever liver insufficiency
  • -Patients with disorders of bone marrow functions or disorders of the hematopoiesis system
  • -genetic induced Glucose-6-phosphate dehydrogenase deficiency (risk of hemolysis)
  • -acute hepatic porphyria
  • -existing hypotony
  • -compromised renal function (creatinine-clearance < 35 ml/min)
  • -pregnant or breast-feeding women (positive pregnancy test for pre-menopausal women)
  • -participation in another interventional AMG study (studies falling in the jurisdiction of German Drug Law)

研究者

发起方
niversity of Leipzig

相似试验